Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 819

1.

Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S.

AJNR Am J Neuroradiol. 2009 Feb;30(2):367-72. doi: 10.3174/ajnr.A1362. Epub 2008 Nov 20.

2.

Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.

Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E, Okawa H, Furukawa Y, Hirai T, Endo M.

J Neurooncol. 2010 Aug;99(1):81-8. doi: 10.1007/s11060-009-0106-z. Epub 2010 Jan 8.

PMID:
20058049
3.

Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.

Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D, Richey K, Park S, Pieper DR, Chen PY, Grills IS.

Magn Reson Imaging. 2011 Sep;29(7):993-1001. doi: 10.1016/j.mri.2011.04.004. Epub 2011 May 14.

PMID:
21571478
4.

Serial MR imaging of intracranial metastases after radiosurgery.

Hawighorst H, Essig M, Debus J, Knopp MV, Engenhart-Cabilic R, Schönberg SO, Brix G, Zuna I, van Kaick G.

Magn Reson Imaging. 1997;15(10):1121-32.

PMID:
9408133
5.

Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M.

AJNR Am J Neuroradiol. 2000 May;21(5):901-9.

6.
7.

Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE.

AJNR Am J Neuroradiol. 2009 Mar;30(3):552-8. doi: 10.3174/ajnr.A1377. Epub 2008 Dec 4.

8.

Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.

Dequesada IM, Quisling RG, Yachnis A, Friedman WA.

Neurosurgery. 2008 Nov;63(5):898-903; discussion 904. doi: 10.1227/01.NEU.0000333263.31870.31.

PMID:
19005380
9.

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S.

Radiology. 2009 Nov;253(2):486-96. doi: 10.1148/radiol.2532090007. Epub 2009 Sep 29.

10.

Clinical and pathological characteristics of brain metastasis resected after failed radiosurgery.

Jagannathan J, Bourne TD, Schlesinger D, Yen CP, Shaffrey ME, Laws ER Jr, Sheehan JP.

Neurosurgery. 2010 Jan;66(1):208-17. doi: 10.1227/01.NEU.0000359318.90478.69.

PMID:
20023552
11.

Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.

Graves EE, Nelson SJ, Vigneron DB, Verhey L, McDermott M, Larson D, Chang S, Prados MD, Dillon WP.

AJNR Am J Neuroradiol. 2001 Apr;22(4):613-24.

12.

[Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].

Weber MA, Lichy MP, Thilmann C, Günther M, Bachert P, Maudsley AA, Delorme S, Schad LR, Debus J, Schlemmer HP.

Radiologe. 2003 May;43(5):388-95. German.

PMID:
12764588
13.
14.

Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.

Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Davis CS, Wen BC, Martin DD, Pelsang RE, Buller RE, Oberley LW, Mellenberg DE, Hussey DH.

Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):623-33.

PMID:
8948347
15.

Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.

Fayed N, Dávila J, Medrano J, Olmos S.

Eur J Radiol. 2008 Sep;67(3):427-33. doi: 10.1016/j.ejrad.2008.02.039. Epub 2008 Apr 28.

PMID:
18442889
16.

Radiosurgery of the metastatic brain tumours with gamma-knife.

Kida Y, Kobayashi T, Tanaka T.

Acta Neurochir Suppl. 1995;63:89-94.

PMID:
7502736
17.

Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A, Litt AW, Zagzag D.

AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1109-16.

18.

Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.

Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, Gonzalez RG, Lev MH.

Acad Radiol. 2010 Mar;17(3):282-90. doi: 10.1016/j.acra.2009.10.024. Epub 2010 Jan 12.

PMID:
20060750
19.

Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.

Chernov MF, Hayashi M, Izawa M, Usukura M, Yoshida S, Ono Y, Muragaki Y, Kubo O, Hori T, Takakura K.

Brain Tumor Pathol. 2006 Apr;23(1):19-27.

PMID:
18095115
20.

Recurrent inverted papilloma: diagnosis with pharmacokinetic dynamic gadolinium-enhanced MR imaging.

Lai PH, Yang CF, Pan HB, Wu MT, Chu ST, Ger LP, Huang WC, Hsu CC, Lee CN.

AJNR Am J Neuroradiol. 1999 Sep;20(8):1445-51.

Supplemental Content

Support Center